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ABSTRACT We have shown that platelets are capable of
phagocytosing liposomes rather than simply sequestering par-
ticles as previously postulated. Incubation of human platelets
with small neutral unilameliar liposomes (:74 nm) resulted in
uptake of the liposomes and retention of the lipid with rapid
release of the aqueous-phase components. The lipid label [3H(-
cholesterylhexadecyl ether and water-soluble (3H]inulin were
used to study the fate of the liposome components. Uptake of
liposomes was proportional to the number of liposomes added
and to the incubation time. Approximately 250 liposomes per
platelet were taken up within a 5-hr incubation period. Uptake
of the liposomes occurred through the open-channel system, as
evidenced by thin-section electron microscopy, and was followed
by accumulation and degradation in acid- and esterase-
containing vesicles, as determined by changes in fluorescence of
the pH-sensitive probe, pyranine (1-hydroxypyrene-3,6,8-
trisulfonic acid), and hydrolysis of the cholesteryl ['4Cloleate
membrane marker. Uptake was inhibited by the addition of
EDTA, cytochalasin B, or 2,4-dinitrophenol and iodoacetate to
the medium. Results from the serotonin release assay, micro-
aggregation assay, fluorescein diacetate membrane integrity
assay, and electron microscopy indicate that neither the condi-
tions for loading nor phagocytosis ofliposomes significantly alter
platelet function or morphology.
Platelets have been shown to take up a variety of particles in
vitro (1-6) and evidence is accumulating which suggests that
removal of foreign materials from the blood may be an
important physiologic role for these cells (7-10). However, it
remains to be definitively demonstrated whether platelets are
truly phagocytic or simply sequester the particles within the
open-channel system (OCS).
In prior work, the platelet-latex sphere system has been
used as a model for foreign particle ingestion by these cells
(2, 3, 11-13). Various studies have shown progressive accu-
mulation of latex spheres in the OCS, a system of channels
believed to be formed by invagination of the plasma mem-
brane. Lewis et al. (13) noted subsequent localization of the
particles in acid phosphatase-positive electron-opaque vac-
uoles and concluded that platelets phagocytose latex parti-
cles. However, White (12) concluded that platelets sequester
latex particles within membrane invaginations, which are in
communication with the exterior of the cell. We report the
use of small neutral unilamellar liposomes to study possible
phagocytosis of particles by platelets. Liposomes have been
used extensively to model microorganism interactions and,
unlike latex beads, are more suitable for the study of uptake,
metabolism, and exocytosis.
MATERIALS AND METHODS
Purification of Platelets. Platelets were prepared by two
methods; experiments measuring uptake using either platelet
preparation gave similar results. Platelet-rich plasma packs
obtained from the Red Cross were diluted in a 1:1 ratio with
0.9%o saline solution. A volume of4.5% dextran (Mr, 250,000)
in saline solution was added to an equal volume ofthe diluted
packs and stirred; erythrocytes were allowed to sediment for
30 min at room temperature. Fifteen-milliliter aliquots of the
supernatant were pipetted into centrifuge tubes. Equal vol-
umes ofa solution containing 6.35% Ficoll and 10o Hypaque
(wt/wt) were gently layered on the bottom of the tubes. The
tubes were spun at 400 x g for 15 min at room temperature.
The cloudy band containing the platelets and lymphocytes
located directly above the Ficoll/Hypaque gradient was
gently removed, diluted in a 1:1 ratio with saline solution, and
centrifuged at 300 x g for 15 min at room temperature to
sediment the lymphocytes. The supernatant was spun at 800
x g for 20 min; the platelet pellet formed was washed twice
in saline solution and finally resuspended in Hanks' balanced
salt solution (HBSS).
Platelets purchased from the American Blood Institute
(Los Angeles) were centrifuged at 1000 x g for 15 min in an
IEC Centra-8 centrifuge. The pellet was resuspended in
either 0.9%o saline solution or Tyrode's buffer and was spun
at 110 x g for 5 min to remove excess erythrocytes. The
supernatant was spun at 450 x g for 10 min. The pellet was
resuspended in HBSS or modified Tyrode's buffer (Tyrode's
buffer plus 1.26 mM CaCl2).
The final purities of both platelet preparations were >95%
platelets as assessed by a Coulter S+4 Cell Counter; the main
contaminants were erythrocytes. Platelets were used within
24 hr of blood collection.
Determination of the Number of Platelets per mg of Protein.
Cell counts were performed with a Coulter S+4 Cell Counter
to determine the number of platelets. The Peterson modifi-
cation of the Lowry protein assay (14) with a bovine serum
albumin standard and without trichloroacetic acid precipita-
tion was used to determine the amounts ofprotein in the same
samples. One milligram of protein was found to correspond
to 3 x 108 platelets.
Preparation of Liposomes. [3HJCholesterylhexadecyl ether-
labeled liposomes. A 2:1 (mol/mol) mixture of distearoyl-
phosphatidylcholine (Avanti Polar Lipids) and cholesterol
(cell culture tested; Sigma) in chloroform was made such that
the total lipid content was -20 mg. Five microcuries (1 Ci =
37 GBq) of [3H]cholesterylhexadecyl ether (New England
Nuclear) in chloroform was also added. The solution was
then taken to dryness in a 100-ml round bottomed flask with
a Buchler "Rotovap" apparatus and was dried under vacuum
overnight. The resulting phospholipid mixture was resus-
pended in 5 ml of phosphate-buffered saline (PBS; 0.90%o
NaCl/0.12% Na2HPO4-7H2O/0.013% NaH2PO4-H2O in wa-
ter, pH 7.3) and Vortex mixed, and 2.5-ml portions were
probe sonicated for 15 min with a Heat Systems-Ultrasonics
sonicator with a microprobe.
p[HJInulin-labeled liposomes. Liposomes were prepared
exactly as described except that no [3H]cholesterylhexadecyl
ether was added and the resuspension buffer contained 5 uCi
of [3H]inulin (Amersham). Excess [3H]inulin (Mr 5200) was
Abbreviations: OCS, open-channel system; HPTS, 1-hydroxypyrene-
3,6,8-trisulfonic acid; FDA, fluorescein diacetate.
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separated from the liposomes by gel filtration with a Seph-
adex G-50-100 column.
Nonradiolabeled liposomes. Liposomes were prepared as
described but without the tritiated labels.
Pyranine (1-Hydroxypyrene-3,6,8-trisulfonic acid; HPTS)-
labeled liposomes. Liposomes were prepared as described
above except that the resuspension solution was 35 mM in
HPTS (Molecular Probes) and 75 mM in NaCl. Excess HPTS
was removed by gel filtration with a Sephadex G-50-100
column equilibrated with 150 mM NaCl.
Cholesteryl ['4Cloleate-labeled liposomes. Liposomes
were prepared as described for the [3H]cholesterylhexadecyl
ether-labeled liposomes except 5 1.Ci of cholesteryl [14C]-
oleate (Amersham) in chloroform was added instead of[3H]cholesterylhexadecyl ether.
Incubation Procedure. Platelets and liposomes were incu-
bated at 370C in 1.5-ml polypropylene centrifuge tubes for the
desired incubation times, after which the mixtures were
centrfifuged at 5700 x g for 5 min in a Beckman Microfuge 11.
The pellets were washed twice in buffer and finally resus-
pended in 0.5 M NaOH/0.5% SDS and incubated overnight
at room temperature. The solution was transferred to liquid
scintillation vials with 10 ml of Safety Solve (Research
Products), mixed, and allowed to sit at least 2 hr before
scintillation counting. For each experiment, all samples were
done in duplicate; the number of independent experiments(n) is noted in the figure legends or in the text. Bars on graphs
represent range of data.
Exocytosis Studies. Platelets and liposomes were incubated
as described above for 12 hr. The mixtures were centrifuged
and platelets were washed by centrifugation twice in buffer to
remove excess liposomes and then further incubated at 370C
for various periods of time. Both the pellets and supernatants
were collected by centrifugation, solubilized in the NaOH/
SDS solution overnight, and assayed.
Determination of Liposome Diameters and Estimation of
Liposome Numbers. Liposome diameters for different prep-
arations were determined by photon correlation spectros-
copy at 480 nm with a Malvern Instruments PCS 100 system.
The numbers of [3H]cholesterylhexadecyl ether-labeled lipo-
somes were calculated by assuming that the counts per
weight of lipid were constant for all preparations, the average
surface area for a phospholipid molecule is 0.7 nm2 (15), and
the average molecular weight for the lipid is 656 g/mol. The
numbers of [3H]inulin-labeled and nonradiolabeled liposomes
were determined by performing Bottcher phosphate assays(16) on the samples and assuming a 0.7-nm2 phospholipid
surface area. The light scattering data indicated that liposome
diameters were 65-83 nm. The numbers of liposomes re-
ported have all been normalized assuming that the diameters
of the liposomes for all experiments were 74 nm.
Fluorimetry of HPTS. After incubation with HPTS-labeled
liposomes for various times, the cells were washed twice with
buffer. Fluorescence excitation spectra (A4, 395-465 nm;
bandwidth, 4 nm) were measured at 510-nm emission (band-
width, 4 nm) using a SLM 4800 (SLMj Urbana, IL) outfitted
with a stirred, temperature-controlled cuvette (20°C). HPTS is
a pH-dependent dye that exhibits two major fluorescence
maxima (403 and 460 nm), which have a complementary pH
dependence in the range pH 5-9; the peak at 403 nm is maximal
at low pH values, while the peak at 460 nm is maximal at high
pH values. The fluorescence at 413 nm is relatively pH
independent and is used to standardize the concentration of
dye associated with the cells. The fraction of liposomes taken
up by phagocytosis and delivered to an acidic (pH 6.0)
environment was calculated by using the 460/413 nm ratio and
the equation
fraction phagocytosed =
(ratiopH 7.4 - ratiomeasured)/(ratiopH 7.4 - ratiopH 6.0),
where ratiomeawsd is the 460/413 ratio of liposome-treated
cells and ratiopH 7.4 and ratiopH 6.0 are the 460/413 ratios of
liposomes in buffer and acidified buffer, respectively (17). In
the original paper by Daleke et al. (17), the second peak
occurred at 450 nm; however, according to our data the peak
maximum is at 460 nm.
Intralysosomal Degradation of the Cholesteryl [14Cjoleate-
Labeled Liposomes. Platelets (3 x 108) were preincubated
with [3H]cholesterylhexadecyl ether or cholesteryl [14C]-
oleate-labeled liposomes (7 x 1011) for 0.5 hr at 370C. The
mixtures were washed twice in buffer by centrifugation. The
pellets were collected, resuspended in buffer, and incubated
for 10-60 min at 370C. After incubation, the mixtures were
centrifuged to collect the pellets that were then solubilized in
NaOH/SDS solution overnight and assayed.
Upon intralysosomal degradation, cholesteryl [14C]oleate
is hydrolyzed to form [14C]oleate, which is released from
cells. Conversely, [3H]cholesterylhexadecyl ether is retained
within the cells. Therefore, by monitoring the 3H/14C ratio of
the pellets, the degree of degradation can be determined (18).
Thin-Sectlon Electr Microscopy. Samples of 3 x 10V
platelets were incubated with 7 x 1011 nonradiolabeled
liposomes for 6 hr at 370C, fixed in a standard fashion, and
embedded in LR white.
In addition, platelets suspended in HBSS or modified
Tyrode's buffer incubated with or without liposomes for 1 hr
at 3TC prepared as described above were studied to deter-
mine changes in platelet morphology under the conditions
used for studying the liposome interaction.
In Vitro Studies to Assess Platelet Function. Serotonin
release assay. The serotonin assay was performed with 3 x
10V platelets suspended in HBSS or in modified Tyrode's
solution and incubated with or without 1.4 x 1012 liposomes
for 1-9 hr as described (19).
Microaggregation assay. Platelets suspended in HBSS or
modified Tyrode's solution were incubated at 370C, with or
without liposomes, for 1-9 hr and then fixed with 1% glutar-
aldehyde. The percentages of aggregated platelets were de-
termined by examining the cells in a hemacytometer.
Fluorescein diacetate (FDA) assay. After incubation of
platelets suspended in HBSS or in modified Tyrode's solution
at 370C, with or without liposomes, for 1-9 hr, FDA (Sigma)
was added and incubated (final concentration, 4 pg/ml) with
the cells for 10 min at room temperature. The platelets were
then kept on ice for 1 min and pelleted at 40C. The fluores-
cence was measured at 520-nm emission while exciting at 489
nm.
FDA is a nonfluorescent probe that readily crosses the cell
membrane. Within the cell the probe is hydrolyzed by
esterases to form fluorescent fluorescein, which does not
readily traverse the cell membrane at 40C but can leak out of
the cells through membrane lesions. Therefore, the leakage of
fluorescein is a measure of loss of membrane integrity (20).
RESULTS
[3flChoesterylbexadecyl Ether-Labeled Liposome Uptake.
To model the liposome uptake by platelets, [3H]cholesteryl-
hexadecyl ether-labeled liposome uptake was studied for
various incubation times and incubation concentrations of
both the liposomes and platelets. Platelet uptake of [3H]cho-
lesterylhexadecyl ether-labeled liposomes increased with in-
creasing incubation times (Fig. 1). After incubation of 3 x 108
platelets with 7 x 1011 liposomes for 5 hr, =250 liposomes
were associated with each platelet. Liposome uptake by
platelets also increased with increasing numbers ofincubated
liposomes; two incubation times are shown (Fig. 2). Incuba-
tion for 12.5 hr resulted in greater uptake values than the
2.0-hr incubation. As the number of platelets incubated with
a constant amount of liposomes was increased, the overall
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FIG. 1. Incubation time dependence ofplatelet uptake of [3H]cho-
lesterylhexadecyl ether-labeled liposomes. Platelets (3 x 108) were
incubated with [3H]cholesterylhexadecyl ether-labeled liposomes (7
x 101") at 370C for various incubation times (n = 8).
number of liposomes incorporated increased (Fig. 3); how-
ever, the ratio of liposomes to platelets remained constant at
=475 liposomes per platelet for a 12.0-hr incubation period.
PH]Inulin-Labeled Liposome Uptake. Uptake of the aque-
ous components of the liposomes was studied by following
the uptake of [3H]inulin-labeled liposomes versus various
incubation times and liposome concentrations. Although the
number of [3f1]inulin-labeled liposomes taken up increased
with time (Fig. 4), the kinetics of uptake were different than
that for the [3H]cholesterylhexadecyl ether-labeled lipo-
somes. Incubation of2 x 1012 liposomes with 3 x 108 platelets
resulted in uptake of '150 liposomes per platelet after 5 hr.
The uptake of [3H]inulin-labeled liposomes versus the con-
centration of liposomes incubated is shown for two different
incubation times (Fig. 5). Uptake was proportional to both
the number of liposomes incubated and the incubation time.
The difference in kinetics of uptake as assessed by the lipid
label and the aqueous label suggests that there is a difference
in the fate of the lipid and aqueous components after platelet
uptake. Therefore, the values reported for the uptake of the
[3H]inulin-labeled liposomes are given as "apparent lipo-
somes per platelet."
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FIG. 3. Platelet concentration dependence of platelet uptake of
[3H]cholesterylhexadecyl ether-labeled liposomes. [3H]Cholesteryl-
hexadecyl ether-labeled liposomes (8.3 x 1011) were incubated with
various numbers of platelets (final volume, 0.5 ml) at 370C for 2.0 hr.
The line representing 475 liposomes per platelet is shown (n = 6).
Release of Tritiated Radiolabels. To study the possible
exocytosis of liposomes, the amounts released ofthe tritiated
radiolabels [3H]cholesterylhexadecyl ether and [3H]inulin
probes were examined (Fig. 6). After 12 hr no membrane-
associated probe was released. However, up to 60% of the
aqueous-phase probe was released during this period.
HPTS-Labeled Liposome Uptake. To determine the per-
centage of liposomes phagocytosed and delivered to acidic
compartments, the uptake of fluorescently labeled (HPTS)
liposomes was measured by fluorimetry versus time (Fig. 7).
Initially, the liposomes were associated with the platelets,
either bound to the surface or contained in the OCS, but were
not phagocytosed. Within minutes the liposomes began to
accumulate in acid-containing vesicles. The percentage of
platelet-associated liposomes phagocytosed increased to
80% within 1 hr.
Cholesteryl [14C]oleate-Labeled Liposome Degradation. Li-
posome degradation was monitored by studying the time
dependence of the relative abundances of 3H and 14C within
the platelets after preincubating the cells with [3H]cho-
lesterylhexadecyl ether- or cholesteryl [14C]oleate-labeled
liposomes for 0.5 hr, washing the pellets twice, and resus-
pending in buffer (n = 10). During a 60-min period, the 3H/14C
ratios within the cells increased linearly from 1.00 at 0 min,
1.028 at 10 min, 1.130 at 20 min, 1.212 at 30 min, and 1.246
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FIG. 2. Liposome concentration dependence of platelet uptake of
[3H]cholesterylhexadecyl ether-labeled liposomes. Platelets (3 x
108) were incubated with various amounts of [3H]cholesterylhexa-
decyl ether-labeled liposomes at 37TC for 2 hr (n) or 12.5 hr (o) (n =
10for2 hr; n = 6for 12.5 hr).
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FIG. 4. Incubation time dependence of platelet uptake of [3H]inu-
lin-labeled liposomes. Platelets (3 x 108) were incubated with 2 x
1012 [3H]inulin-labeled liposomes at 37TC for various incubation times
(n = 6).
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FIG. 5. Liposome concentration dependence ofplatelet uptake of
[3H]inulin-labeled liposomes. Platelets (3 x 108) were incubated with
various amounts of VH]inulin-labeled liposomes at 3TC for 6.0 hr (a)
and 12.5 hr (0) (n = 6).
at 50 min, to 1.294 at 60 min. [3H]Cholesterylhexadecyl ether
was retained within the platelets; however, the cholesteryl
[14C]oleate was hydrolyzed to form [14C]oleate, which was
released by the cells. Therefore, the increase in the 3H/14C
ratio in the cells was indicative of degradation of the lipo-
somes. The amount of liposome degradation is probably
underestimated since incubations were done in the absence of
serum, which is unfavorable for the release of oleate (21).
Electron Microscopy. Electron microscopy was performed
to study the effects ofHBSS and modified Tyrode's solution
and the phagocytosis ofliposomes on platelet morphology (n
= 4). The effects of incubation of up to 2.1 x 1012 liposomes
were studied.
Platelets maintained a discoid shape when suspended in
modified Tyrode's buffer. However, platelets suspended in
HBSS tended to have irregular shapes and approximately half
had pseudopodia. Therefore, we believe that incubation in
modified Tyrode's buffer is superior. Incubation with lipo-
somes did not significantly alter platelet morphology.
Competitive Assay. A competitive assay was performed to
establish whether liposome uptake could be saturated. Pre-
incubation of platelets with 0-3.4 x 1012 nonradiolabeled
liposomes prior to two centrifugation washes and incubation
with 7.9 x 1011 tritiated liposomes for preincubation times of
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FIG. 7. Incubation time dependence ofthe percentage of platelet-
associated HPTS-labeled liposomes phagocytosed. Platelets (3 x
108) were incubated with 7 x 1Wl HPTS-labeled liposomes at 370C
for various incubation times. Cells were then pelleted, washed twice
in buffer, and resuspended in buffer. Percentages of platelet-
associated liposomes phagocytosed were calculated (n = 6).
0.5, 2, and 6 hr and incubation times of 0.17, 0.5, 2, and 6 hr
gave similar results (data not shown; n = 4). The amount of
[3H]cholesterylhexadecyl ether liposomes taken up was in-
dependent of the amount of nonradiolabeled liposomes pre-
viously added. In addition, uptake was relatively indepen-
dent of the preincubation time, while uptake increased with
increasing incubation times. Simultaneous incubation ofnon-
radiolabeled and 3H-labeled liposomes resulted in a linear
decrease in uptake of the 3H-labeled liposomes as expected.
Inhibition of Liposome Uptake. The inhibitory effects of a
variety ofreagents known to decrease platelet uptake oflatex
spheres were examined during platelet incubation with lipo-
somes. Incubation for 12 hr in the presence of 5 mM EDTA
inhibited the uptake of liposomes by 48% + 91%; however,
incubation for 1 hr showed no significant inhibition ofuptake
(n = 10). The addition of cytochalasin B (10 pg/ml) (n = 8)
or 0.25 mM 2,4-dinitrophenol with 50 juM iodoacetate (n = 8)
also inhibited uptake by 46% ± 16% and 66% ± 12%,
respectively.
In Vitro Assays to Assess Platelet Function. Although the
numbers of liposomes phagocytosed by platelets suspended
in HBSS or modified Tyrode's buffer are identical, the in
vitro assays showed that platelets, incubated with or without
liposomes, spontaneously secrete serotonin, aggregate, and
lose membrane integrity more while suspended in HBSS.
However, phagocytosis of liposomes did not significantly
alter platelet secretion of serotonin or induce additional
platelet aggregation or loss of membrane integrity. This was
not surprising since it had been previously shown that the
uptake of Intralipid, a lipid emulsion used in treatment of
patients with deficient caloric intake, does not increase
platelet aggregation or induce morphological changes (22).
DISCUSSION
We have determined that platelets are capable of phagocy-
8 1 0 1 2 tosing small unilameilar liposomes rather than sequestering
particles as postulated (12). Liposomes are taken up through
the OCS, localize within acid- and esterase-containing vesi-
us probes. Platelets (3 cles, and are degraded. The lipid is retained; the aqueous
l]cholesterylhexadecyl components are exocytosed. Therefore, all uptake values
Ed (a) liposomes at 37C reported using [3H]inulin-labeled liposomes really reflect a
ished twice in buffer, consecutive first-order kinetic scheme of uptake and exocy-
ious incubation times at tosis.
xadecyl ether and the The values reported in this paper for platelet uptake do not
.termined (n = 6). differentiate between incorporated and bound liposomes.
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However, according to electron micrographs, the vast ma-
jority of the liposomes appear to be within the OCS. In
addition, the use of a pH-dependent fluorescent liposome
probe confirms that a substantial portion of the liposomes are
phagocytosed and are in acid-containing compartments.
These data suggest that the liposomes are incorporated in
surface invaginations, which pinch off their connections to
the cell membrane and migrate into the cytoplasm as sealed
vesicles, rather than being sequestered in the OCS and in
contact with the outside medium. Degradation of the lipo-
somes, which probably occurs in the acid phosphatase- and
esterase-containing vacuoles, has also been demonstrated by
utilizing cholesteryl [14C]oleate-labeled liposomes. The
mechanism for release of the aqueous components to the
outside of the cell probably involves migration of these
vacuoles to the periphery of the cell and exocytosis of their
contents; however, this has not been confirmed.
Although the space available for uptake within the cell
must be limited, exocytosis ofthe aqueous components ofthe
liposomes increases the amount of liposome lipid capable of
being stored as detected by the [3H]cholesterylhexadecyl
ether label. With the amounts of liposomes and platelets used
and on the time scale of the preincubation experiments, the
space available for uptake is not saturable. The uptake is
independent of the amount of nonradiolabeled liposomes
added and of preincubation times. Simultaneous incubation
of nonradiolabeled and radiolabeled liposomes demonstrates
a dilution effect, which results in decreased uptake of the
radiolabeled liposomes.
According to Mustard and Packham (3), the addition of
EDTA inhibits phagocytosis of particles and platelet aggre-
gation, but it does not interfere with particle adherence.
Liposome uptake is inhibited by the presence of EDTA at
long time intervals but not at short intervals when the
predominant process ofuptake in the absence of Ca2+ may be
binding. This evidence suggests that divalent cations are
involved in the phagocytosis process; however, the effects of
different divalent cations have not been investigated. The
inhibitory effect of cytochalasin B with respect to platelet
uptake has been attributed to its effect on microfilaments and
the plasticity of the platelet membrane (23). The addition of
2,4-dinitrophenol and iodoacetate before incubation blocks
aggregation and phagocytosis by interfering with glycolysis
and oxidative phosphorylation (2). Liposome uptake is Ca2+
dependent; however; platelets tend to aggregate and secrete
more in the presence of Ca2+. Therefore, we studied the
effects of HBSS and modified Tyrode's buffer on the mor-
phology and function of platelets, which both contained 1.26
mM CaC12. The serotonin release assay, microaggregation
assay, and FDA membrane integrity assay all show that
platelet function and morphology are better preserved in
modified Tyrode's buffer than in HBSS. However, even in
modified Tyrode's buffer, the loss of membrane integrity is
significant. This loss may be due to incubation ofthe platelets
in small polypropylene centrifuge tubes at 37°C. It is prefer-
able to store platelets at room temperature, but phagocytosis
is maximized at 37°C. The assays also indicated that phago-
cytosis of liposomes does not adversely affect the platelets.
Although we began this research to define the mechanisms
involved in platelet-liposome interactions, we realize the
ability to encapsulate a variety of drugs or radioactive labels
in vitro in platelets and to target specific locations in vivo such
as areas of inflammation or infection, neoplastic tumor cells,
or thrombosis would be of great medical importance. The
exocytosis process is comparatively rapid; the half-life of the
aqueous compartment calculated assuming a first-order re-
action is 3.9 hr. Therefore, it may be necessary to use
inhibitors that would slow the digestion of the liposomes or
the release of the liposomes' aqueous components. Alterna-
tively, lipid analogs of the drugs could be used for longer
platelet retention. In some cases, rapid release of drugs from
the aqueous compartments may be desirable. An example of
this might be the delivery of thrombolytic agents to a coro-
nary thrombus in the initial treatment of myocardial infarc-
tion.
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